img

Global Sitagliptin Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 95 | Industry : Pharma & Healthcare

Publisher : Q | Format : PDF

Global Sitagliptin Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Injection
Tablets


Segment by Application


Diabetes
Epilepsy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


Merck
De Xiang Pharmaceutical&Chemicals
Yonta
Haikang Pharma
Baoling Pharma
Phebra

Table of Content

1 Sitagliptin Market Overview
1.1 Product Overview and Scope of Sitagliptin
1.2 Sitagliptin Segment by Type
1.2.1 Global Sitagliptin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection
1.2.3 Tablets
1.3 Sitagliptin Segment by Application
1.3.1 Sitagliptin Sales Comparison by Application: (2021-2027)
1.3.2 Diabetes
1.3.3 Epilepsy
1.3.4 Others
1.4 Global Sitagliptin Market Size Estimates and Forecasts
1.4.1 Global Sitagliptin Revenue 2016-2027
1.4.2 Global Sitagliptin Sales 2016-2027
1.4.3 Sitagliptin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Sitagliptin Market Competition by Manufacturers
2.1 Global Sitagliptin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sitagliptin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sitagliptin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sitagliptin Manufacturing Sites, Area Served, Product Type
2.5 Sitagliptin Market Competitive Situation and Trends
2.5.1 Sitagliptin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sitagliptin Players Market Share by Revenue
2.5.3 Global Sitagliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Sitagliptin Retrospective Market Scenario by Region
3.1 Global Sitagliptin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Sitagliptin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Sitagliptin Market Facts & Figures by Country
3.3.1 North America Sitagliptin Sales by Country
3.3.2 North America Sitagliptin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sitagliptin Market Facts & Figures by Country
3.4.1 Europe Sitagliptin Sales by Country
3.4.2 Europe Sitagliptin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sitagliptin Market Facts & Figures by Region
3.5.1 Asia Pacific Sitagliptin Sales by Region
3.5.2 Asia Pacific Sitagliptin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sitagliptin Market Facts & Figures by Country
3.6.1 Latin America Sitagliptin Sales by Country
3.6.2 Latin America Sitagliptin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sitagliptin Market Facts & Figures by Country
3.7.1 Middle East and Africa Sitagliptin Sales by Country
3.7.2 Middle East and Africa Sitagliptin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Sitagliptin Historic Market Analysis by Type
4.1 Global Sitagliptin Sales Market Share by Type (2016-2021)
4.2 Global Sitagliptin Revenue Market Share by Type (2016-2021)
4.3 Global Sitagliptin Price by Type (2016-2021)

5 Global Sitagliptin Historic Market Analysis by Application
5.1 Global Sitagliptin Sales Market Share by Application (2016-2021)
5.2 Global Sitagliptin Revenue Market Share by Application (2016-2021)
5.3 Global Sitagliptin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Sitagliptin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 De Xiang Pharmaceutical&Chemicals
6.2.1 De Xiang Pharmaceutical&Chemicals Corporation Information
6.2.2 De Xiang Pharmaceutical&Chemicals Description and Business Overview
6.2.3 De Xiang Pharmaceutical&Chemicals Sitagliptin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 De Xiang Pharmaceutical&Chemicals Product Portfolio
6.2.5 De Xiang Pharmaceutical&Chemicals Recent Developments/Updates
6.3 Yonta
6.3.1 Yonta Corporation Information
6.3.2 Yonta Description and Business Overview
6.3.3 Yonta Sitagliptin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Yonta Product Portfolio
6.3.5 Yonta Recent Developments/Updates
6.4 Haikang Pharma
6.4.1 Haikang Pharma Corporation Information
6.4.2 Haikang Pharma Description and Business Overview
6.4.3 Haikang Pharma Sitagliptin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Haikang Pharma Product Portfolio
6.4.5 Haikang Pharma Recent Developments/Updates
6.5 Baoling Pharma
6.5.1 Baoling Pharma Corporation Information
6.5.2 Baoling Pharma Description and Business Overview
6.5.3 Baoling Pharma Sitagliptin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Baoling Pharma Product Portfolio
6.5.5 Baoling Pharma Recent Developments/Updates
6.6 Phebra
6.6.1 Phebra Corporation Information
6.6.2 Phebra Description and Business Overview
6.6.3 Phebra Sitagliptin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Phebra Product Portfolio
6.6.5 Phebra Recent Developments/Updates

7 Sitagliptin Manufacturing Cost Analysis
7.1 Sitagliptin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sitagliptin
7.4 Sitagliptin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sitagliptin Distributors List
8.3 Sitagliptin Customers

9 Sitagliptin Market Dynamics
9.1 Sitagliptin Industry Trends
9.2 Sitagliptin Growth Drivers
9.3 Sitagliptin Market Challenges
9.4 Sitagliptin Market Restraints

10 Global Market Forecast
10.1 Sitagliptin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sitagliptin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Sitagliptin by Type (2022-2027)
10.2 Sitagliptin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sitagliptin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Sitagliptin by Application (2022-2027)
10.3 Sitagliptin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sitagliptin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Sitagliptin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Sitagliptin Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Sitagliptin Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Sitagliptin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Sitagliptin Covered in This Study
Table 5. Global Sitagliptin Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Sitagliptin Sales Share by Manufacturers (2016-2021)
Table 7. Global Sitagliptin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sitagliptin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Sitagliptin Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Sitagliptin Manufacturing Sites and Area Served
Table 11. Manufacturers Sitagliptin Product Type
Table 12. Global Sitagliptin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sitagliptin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sitagliptin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Sitagliptin Sales by Region (2016-2021) & (K Units)
Table 16. Global Sitagliptin Sales Market Share by Region (2016-2021)
Table 17. Global Sitagliptin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Sitagliptin Sales by Country (2016-2021) & (K Units)
Table 19. North America Sitagliptin Sales Market Share by Country (2016-2021)
Table 20. North America Sitagliptin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Sitagliptin Revenue Market Share by Country (2016-2021)
Table 22. Europe Sitagliptin Sales by Country (2016-2021) & (K Units)
Table 23. Europe Sitagliptin Sales Market Share by Country (2016-2021)
Table 24. Europe Sitagliptin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Sitagliptin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Sitagliptin Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Sitagliptin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Sitagliptin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Sitagliptin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Sitagliptin Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Sitagliptin Sales Market Share by Country (2016-2021)
Table 32. Latin America Sitagliptin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Sitagliptin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Sitagliptin Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Sitagliptin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Sitagliptin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Sitagliptin Revenue Market Share by Country (2016-2021)
Table 38. Global Sitagliptin Sales (K Units) by Type (2016-2021)
Table 39. Global Sitagliptin Sales Market Share by Type (2016-2021)
Table 40. Global Sitagliptin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Sitagliptin Revenue Share by Type (2016-2021)
Table 42. Global Sitagliptin Price (US$/Unit) by Type (2016-2021)
Table 43. Global Sitagliptin Sales (K Units) by Application (2016-2021)
Table 44. Global Sitagliptin Sales Market Share by Application (2016-2021)
Table 45. Global Sitagliptin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Sitagliptin Revenue Share by Application (2016-2021)
Table 47. Global Sitagliptin Price (US$/Unit) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Sitagliptin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Merck Sitagliptin Product
Table 52. Merck Recent Developments/Updates
Table 53. De Xiang Pharmaceutical&Chemicals Corporation Information
Table 54. De Xiang Pharmaceutical&Chemicals Description and Business Overview
Table 55. De Xiang Pharmaceutical&Chemicals Sitagliptin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. De Xiang Pharmaceutical&Chemicals Sitagliptin Product
Table 57. De Xiang Pharmaceutical&Chemicals Recent Developments/Updates
Table 58. Yonta Corporation Information
Table 59. Yonta Description and Business Overview
Table 60. Yonta Sitagliptin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Yonta Sitagliptin Product
Table 62. Yonta Recent Developments/Updates
Table 63. Haikang Pharma Corporation Information
Table 64. Haikang Pharma Description and Business Overview
Table 65. Haikang Pharma Sitagliptin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Haikang Pharma Sitagliptin Product
Table 67. Haikang Pharma Recent Developments/Updates
Table 68. Baoling Pharma Corporation Information
Table 69. Baoling Pharma Description and Business Overview
Table 70. Baoling Pharma Sitagliptin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Baoling Pharma Sitagliptin Product
Table 72. Baoling Pharma Recent Developments/Updates
Table 73. Phebra Corporation Information
Table 74. Phebra Description and Business Overview
Table 75. Phebra Sitagliptin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Phebra Sitagliptin Product
Table 77. Phebra Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Sitagliptin Distributors List
Table 81. Sitagliptin Customers List
Table 82. Sitagliptin Market Trends
Table 83. Sitagliptin Growth Drivers
Table 84. Sitagliptin Market Restraints
Table 85. Global Sitagliptin Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Sitagliptin Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Sitagliptin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Sitagliptin Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Sitagliptin Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Sitagliptin Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Sitagliptin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Sitagliptin Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Sitagliptin Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Sitagliptin Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Sitagliptin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Sitagliptin Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sitagliptin
Figure 2. Global Sitagliptin Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Sitagliptin Market Share by Application in 2020 & 2027
Figure 6. Diabetes
Figure 7. Epilepsy
Figure 8. Others
Figure 9. Global Sitagliptin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Sitagliptin Market Size 2016-2027 (US$ Million)
Figure 11. Global Sitagliptin Sales 2016-2027 (K Units)
Figure 12. Global Sitagliptin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Sitagliptin Sales Share by Manufacturers in 2020
Figure 14. Global Sitagliptin Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Sitagliptin Players: Market Share by Revenue in 2020
Figure 16. Sitagliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Sitagliptin Sales Market Share by Region (2016-2021)
Figure 18. Global Sitagliptin Sales Market Share by Region in 2020
Figure 19. Global Sitagliptin Revenue Market Share by Region (2016-2021)
Figure 20. Global Sitagliptin Revenue Market Share by Region in 2020
Figure 21. U.S. Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Sitagliptin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Sitagliptin by Type (2016-2021)
Figure 46. Sales Market Share of Sitagliptin by Application (2016-2021)
Figure 47. Sales Market Share of Sitagliptin by Application in 2020
Figure 48. Revenue Share of Sitagliptin by Application (2016-2021)
Figure 49. Revenue Share of Sitagliptin by Application in 2020
Figure 50. Manufacturing Cost Structure of Sitagliptin
Figure 51. Manufacturing Process Analysis of Sitagliptin
Figure 52. Sitagliptin Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed